Published in Clin Rheumatol on February 08, 2010
Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus. J Immunol (2011) 1.85
An essential role of caspase 1 in the induction of murine lupus and its associated vascular damage. Arthritis Rheumatol (2014) 1.78
Neutrophil extracellular trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages. J Immunol (2012) 1.44
The inflammasome and lupus: another innate immune mechanism contributing to disease pathogenesis? Curr Opin Rheumatol (2014) 1.08
Neutrophil Extracellular Traps and Systemic Lupus Erythematosus. J Clin Cell Immunol (2013) 0.95
IL-27 Regulates IL-18 binding protein in skin resident cells. PLoS One (2012) 0.87
Serum IL-18 as biomarker in predicting long-term renal outcome among pediatric-onset systemic lupus erythematosus patients. Medicine (Baltimore) (2016) 0.75
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1997) 43.47
Glomerular accumulation of plasmacytoid dendritic cells in active lupus nephritis: role of interleukin-18. Arthritis Rheum (2008) 1.52
IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology. J Immunol (2003) 1.51
Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis. Arthritis Rheum (2002) 1.27
Expression and release of IL-18 binding protein in response to IFN-gamma. J Immunol (2001) 1.19
A proinflammatory role of IL-18 in the development of spontaneous autoimmune disease. J Immunol (2001) 1.14
Role of IFN-gamma in Th1 differentiation: IFN-gamma regulates IL-18R alpha expression by preventing the negative effects of IL-4 and by inducing/maintaining IL-12 receptor beta 2 expression. J Immunol (2002) 1.11
Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein. J Immunol (2003) 1.08
IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease. Proc Natl Acad Sci U S A (2003) 1.06
Interferon-gamma mediates gene expression of IL-18 binding protein in nonleukocytic cells. Biochem Biophys Res Commun (2000) 1.06
Elevated production of interleukin-18 is associated with renal disease in patients with systemic lupus erythematosus. Clin Exp Immunol (2002) 0.99
IL-18 activity in systemic lupus erythematosus. Ann N Y Acad Sci (2009) 0.97
Interleukin-18 binding protein transgenic mice are protected against ischemic acute kidney injury. Am J Physiol Renal Physiol (2008) 0.97
Evidence for a pathogenetic role of interleukin-18 in cutaneous lupus erythematosus. Arthritis Rheum (2008) 0.90
Elevation of plasma interleukin-18 concentration is associated with insulin levels in patients with systemic lupus erythematosus. Lupus (2006) 0.83
Proinflammatory interferon-gamma--inducing monokines (interleukin-12, interleukin-18, interleukin-15)--serum profile in patients with systemic lupus erythematosus. Eur Cytokine Netw (2002) 0.83
Imbalance of interleukin 18 and interleukin 18 binding protein in patients with lupus nephritis. Cell Mol Immunol (2006) 0.81
Interleukin-18 binding protein in the sera of patients with Wegener's granulomatosis. J Clin Immunol (2008) 0.81
Regulation of interleukin-18 binding protein production by blood and synovial cells from patients with rheumatoid arthritis. Arthritis Rheum (2004) 0.76
Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol (2007) 3.49
MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum (2009) 3.44
miR-155 and its star-form partner miR-155* cooperatively regulate type I interferon production by human plasmacytoid dendritic cells. Blood (2010) 1.71
Interferon-α priming promotes lipid uptake and macrophage-derived foam cell formation: a novel link between interferon-α and atherosclerosis in lupus. Arthritis Rheum (2011) 1.68
Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proc Natl Acad Sci U S A (2010) 1.63
Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells. Arthritis Rheum (2008) 1.58
Identification of microRNA-31 as a novel regulator contributing to impaired interleukin-2 production in T cells from patients with systemic lupus erythematosus. Arthritis Rheum (2012) 1.54
MicroRNA-125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosus. Arthritis Rheum (2010) 1.45
Safety of infliximab therapy in rheumatoid arthritis patients with previous exposure to hepatitis B virus. Int J Rheum Dis (2013) 1.39
Haemogenic endocardium contributes to transient definitive haematopoiesis. Nat Commun (2013) 1.36
Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients. Arthritis Res Ther (2008) 1.23
Synergistic toxicity of the environmental neurotoxins methylmercury and β-N-methylamino-L-alanine. Neuroreport (2012) 0.97
Multidimensional single cell based STAT phosphorylation profiling identifies a novel biosignature for evaluation of systemic lupus erythematosus activity. PLoS One (2011) 0.95
Efficacy and safety of adalimumab in Chinese adults with active ankylosing spondylitis: results of a randomised, controlled trial. Ann Rheum Dis (2013) 0.95
ZnO nanorods/Au hybrid nanocomposites for glucose biosensor. Biosens Bioelectron (2010) 0.93
Role of GADD45 beta in the regulation of synovial fluid T cell apoptosis in rheumatoid arthritis. Clin Immunol (2008) 0.89
An economic evaluation for prevention of diabetes mellitus in a developing country: a modelling study. BMC Public Health (2013) 0.89
Metadherin contributes to the pathogenesis of diffuse large B-cell lymphoma. PLoS One (2012) 0.87
The Akt/GSK-3β pathway mediates flurbiprofen-induced neuroprotection against focal cerebral ischemia/reperfusion injury in rats. Biochem Biophys Res Commun (2011) 0.86
Deficiency of β-arrestin1 ameliorates collagen-induced arthritis with impaired TH17 cell differentiation. Proc Natl Acad Sci U S A (2013) 0.85
Interferon-induced protein IFIT4 is associated with systemic lupus erythematosus and promotes differentiation of monocytes into dendritic cell-like cells. Arthritis Res Ther (2008) 0.85
CCND1 G870A polymorphism with altered cyclin D1 transcripts expression is associated with the risk of glioma in a Chinese population. DNA Cell Biol (2012) 0.85
Dysregulated expression of interleukin-23 and interleukin-12 subunits in systemic lupus erythematosus patients. Mod Rheumatol (2007) 0.84
A comparison study of a recombinant tumor necrosis factor receptor:Fc fusion protein (rhTNFR:Fc) and methotrexate in treatment of patients with active rheumatoid arthritis in China. Rheumatol Int (2008) 0.84
Layer-by-layer self-assembly of functionalized graphene nanoplates for glucose sensing in vivo integrated with on-line microdialysis system. Biosens Bioelectron (2011) 0.83
Size-controllable gold-platinum alloy nanoparticles on nine functionalized ionic-liquid surfaces and their application as electrocatalysts for hydrogen peroxide reduction. Chemistry (2011) 0.82
High expression and nuclear localization of β-catenin in diffuse large B-cell lymphoma. Mol Med Rep (2012) 0.82
An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia. Int J Rheum Dis (2014) 0.82
Losartan, an angiotensin II type 1 receptor blocker, ameliorates cerebral ischemia-reperfusion injury via PI3K/Akt-mediated eNOS phosphorylation. Brain Res Bull (2012) 0.82
Elevated interleukin-18 and skewed Th1:Th2 immune response in lupus nephritis. Rheumatol Int (2010) 0.81
Tetramethylpyrazine analogue CXC195 protects against cerebral ischemia/reperfusion injury in the rat by an antioxidant action via inhibition of NADPH oxidase and iNOS expression. Pharmacology (2013) 0.80
Using pure protein to build a multiple reaction monitoring mass spectrometry assay for targeted detection and quantitation. Methods Mol Biol (2013) 0.80
MYPT1 sustains centromeric cohesion and the spindle-assembly checkpoint. J Genet Genomics (2013) 0.79
Stathmin expression in glioma-derived microvascular endothelial cells: a novel therapeutic target. Oncol Rep (2011) 0.79
Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial. Chin Med J (Engl) (2003) 0.78
Anti-inflammatory effect of acetylpuerarin on eicosanoid signaling pathway in primary rat astrocytes. J Mol Neurosci (2013) 0.78
MicroRNA-9 inhibits vasculogenic mimicry of glioma cell lines by suppressing Stathmin expression. J Neurooncol (2013) 0.78
HRCT score and serum ferritin level are factors associated to the 1-year mortality of acute interstitial lung disease in clinically amyopathic dermatomyositis patients. Clin Rheumatol (2015) 0.78
[C3(OH)2mim][BF4]-Au/Pt biosensor for glutamate sensing in vivo integrated with on-line microdialysis system. Biosens Bioelectron (2010) 0.77
Thiol-dependent DNA cleavage by aminomethylated Beaucage's reagent. Org Biomol Chem (2010) 0.77
Inhibition of sPLA₂-IIA prevents LPS-induced neuroinflammation by suppressing ERK1/2-cPLA₂α pathway in mice cerebral cortex. PLoS One (2013) 0.76
The effects of ultrasound and arsenic trioxide on neurogliocytoma cells and secondary activation of macrophages. Tumori (2010) 0.76
An i-motif-containing DNA device that breaks certain forms of Watson-Crick interactions. Chem Commun (Camb) (2007) 0.76
[Association between Bcl-2 gene polymorphism with systemic lupus erythematosus]. Zhonghua Yi Xue Za Zhi (2002) 0.75
Poor Prognosis in Acute Myeloid Leukemia Patients with Monosomal Karyotype. Turk J Haematol (2016) 0.75
[Expression of fusion proteins in beta(2)GP I gene-transfected HEp-2 cells and its clinical application]. Zhonghua Yi Xue Za Zhi (2002) 0.75
Transfection, overexpression and clinical application of human 60 kDa Ro/SSA autoantigens in HEp-2 cells. Chin Med J (Engl) (2003) 0.75
Chest imaging manifestations in lupus nephritis. Clin Rheumatol (2014) 0.75
Corrigendum: Targeting miR-155 to Treat Experimental Scleroderma. Sci Rep (2016) 0.75
Manipulating open-circuit voltage in an organic photovoltaic device via a phenylalkyl side chain. Chem Commun (Camb) (2013) 0.75
Dumbbell-shaped circular oligonucleotides as inhibitors of human topoisomerase I. Bioorg Med Chem Lett (2007) 0.75
Ligustri lucidi fructus as a traditional Chinese medicine: a review of its phytochemistry and pharmacology. Nat Prod Res (2014) 0.75
Ultrasensitive fluorescence polarization aptasensors based on exonuclease signal amplification and polystyrene nanoparticle amplification. Chem Asian J (2014) 0.75
L-Carnitine Attenuates Cardiac Dysfunction by Ischemic Insults Through Akt Signaling Pathway. Toxicol Sci (2017) 0.75
Composites of polyaniline nanofibers and molecularly imprinted polymers for recognition of nitroaromatic compounds. Chemistry (2011) 0.75
[Association between Bcl-2 gene polymorphism with systemic lupus erythematosus]. Zhonghua Yi Xue Za Zhi (2002) 0.75
Continuous flow Sonogashira C-C coupling using a heterogeneous palladium-copper dual reactor. Org Lett (2012) 0.75